Meta's 'Community Notes' model will not apply to paid ads, WSJ reports-March 2024-www.financetom.com

Meta's 'Community Notes' model will not apply to paid ads, WSJ reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Meta's 'Community Notes' model will not apply to paid ads, WSJ reports

Jan 16, 2025 5:11 PM

Jan 16 (Reuters) - Facebook parent Meta assured

advertisers this week that its "community notes", similar to

that used on Elon Musk-owned social media platform X, will not

apply to paid ads when they arrive later this year, the Wall

Street Journal reported on Thursday.

Previous page： Advanced Drainage Systems Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises Fiscal 2026 Revenue Guidance Next page： Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Advanced Drainage Systems Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises Fiscal 2026 Revenue Guidance

Nov 6, 2025

07:08 AM EST, 11/06/2025 (MT Newswires) -- Advanced Drainage Systems ( WMS ) reported fiscal Q2 adjusted earnings Thursday of $1.97 per diluted share, up from $1.70 a year earlier. Analysts surveyed by FactSet expected $1.64. Revenue for the quarter ended Sept. 30 was $850.4 million, compared with $782.6 million a year earlier. Analysts surveyed by FactSet expected $801 million....

Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows

Nov 6, 2025

Overview * Aclaris Q3 revenue beats analyst expectations despite a year-over-year decline * Net loss for Q3 smaller than expected, reflecting better financial performance * Company reports positive Phase 2a trial results for ATI-2138 in atopic dermatitis Outlook * Aclaris plans Phase 2 trial of ATI-2138 in H1 2026 for new indications * Company expects Phase 1b trials of ATI-052...

ProQR Q3 revenue misses estimates, reports net loss

Nov 6, 2025

Overview * ProQR Q3 revenue missed analyst expectations * Company reported a net loss of €11 mln for Q3 2025 * ProQR received CTA authorization for Phase 1 trial of AX-0810 Outlook * ProQR expects initial safety data for AX-0810 by end of 2025 * Target engagement data for AX-0810 expected in H1 2026 Result Drivers * CASH POSITION -...

ConocoPhillips Q3 profit beats on increased production volumes

Nov 6, 2025

Overview * ConocoPhillips ( COP ) Q3 adjusted EPS of $1.61 beats analyst expectations * ConocoPhillips ( COP ) raises quarterly dividend by 8% to $0.84 per share Outlook * ConocoPhillips ( COP ) expects 2026 capital expenditures of $12 bln * Company forecasts 2026 adjusted operating costs at $10.2 bln * ConocoPhillips ( COP ) anticipates 0 to 2%...